January 3, 2026

A University of Toronto–led study has identified a potential biomarker associated with disease progression in multiple sclerosis (MS), which

Scientists and clinicians can more accurately evaluate precision genome-editing technologies using a newly developed method reported today by St.

Placenta accreta spectrum (PAS), once considered a rare obstetric condition, now affects an estimated 14,000 pregnancies each year and